Accel-Rx is Canada’s health sciences accelerator supporting health innovation companies developing pharmaceuticals, medical devices and diagnostics.

Accel-Rx was created to bridge that gap and is the only organization with a national perspective addressing these specific growth challenges.

Accel-Rx provides $500K in seed funding, which is further matched by third-party investors. Supporting capital financing needs is just one part of the solution – Accel-Rx also offers a full range of programs to address early-stage operating needs including mentorship, business services, training, and networking.

Through a collaborative partnership-based program, portfolio companies draw upon Accel-Rx’s entrepreneurial and commercial expertise, investment, and capital market experience, and extensive networks within the health sciences sector to help drive their growth.